NCT06600022 2025-01-16Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.Sinocelltech Ltd.Phase 1/2 Recruiting441 enrolled